MedPath

Relationship between advanced glycogen endproduct level measured by non-invasive fluorescent AGE analyzer and FGM-monitored glycemic fluctuations in type 2 diabetes

Not Applicable
Conditions
type 2 diabetes.
Registration Number
JPRN-UMIN000047750
Lead Sponsor
Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria for the subjects are as follow. 1. Subjects with acute and/or chronic inflammation 2. Subjects with fresh cardiovascular and/or cerebrovascular diseases 3. Subjects with liver cirrhosis. 4. Subjects with severe respiratory disease or severe heart failure 5. Subjects with alcoholicsm or medicinal intoxication 6. Subjects with psychosis 7. Subjects who doctors judge as unfitness

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath